Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Allopurinol on Insulin Resistance in Hyperuricemia
NCT02008968Unknown
- Sponsor
- Istanbul Medeniyet University
- Start
- Dec 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of allopurinol in prediabetes and insulin resistance (IR) (3 arms), sponsored by Istanbul Medeniyet University. Primary endpoint: Homeostatic Model Assessment of Insulin Resistance at 3 months. Status: unknown.
02
Drugs
allopurinol
03
Conditions
prediabetesinsulin resistance (IR)
Beyond the preview
Go deeper on NCT02008968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008968.